New paradigms in the treatment of low-risk thyroid cancer-Reference-Cited by-同舟云学术

New paradigms in the treatment of low-risk thyroid cancer

Published:2020-06-08 Issue:4 Volume:15 Page:251-260
ISSN:1744-6651
Container-title:Expert Review of Endocrinology & Metabolism
language:en
Short-container-title:Expert Review of Endocrinology & Metabolism

Author:

Baidoun Firas¹,Saad Anas M.¹^ORCID,Abdel-Rahman Omar²

Affiliation:

1. Internal medicine department, Cleveland Clinic Foundation, Cleveland, OH, USA

2. Department of Oncology, University of Alberta, Cross Cancer Institute, Edmonton, Alberta, Canada

Publisher

Informa UK Limited

Subject

Endocrinology, Diabetes and Metabolism

Link

https://www.tandfonline.com/doi/pdf/10.1080/17446651.2020.1773802

Reference106 articles.

1. An Updated Systematic Review and Commentary Examining the Effectiveness of Radioactive Iodine Remnant Ablation in Well-Differentiated Thyroid Cancer

2. International Agency for Research on Cancer. [cited 2020 May 1]. Available from: http://gco.iarc.fr/today/data/factsheets/cancers/32-Thyroid-fact-sheet.pdf.

3. Cancer statistics, 2018

4. National Cancer Institute Surveillance. Epidemiology, and end results program. cancer stat facts: thyroid cancer; 2018. [cited 2020 May 1]. Available from: https://seer.cancer.gov/statfacts/html/thyro.html. Available at: https://seer.cancer.gov/

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of surgery in small differentiated thyroid cancer;Endocrine;2022-06-03

2. Selective Use of Radioactive Iodine Therapy for Papillary Thyroid Cancers With Low or Lower-Intermediate Recurrence Risk;The Journal of Clinical Endocrinology & Metabolism;2020-12-30